Chemed Corporation
CHE · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.06 | -1.27 | -1.63 | 1.06 |
| FCF Yield | 1.01% | 1.73% | 0.22% | 1.93% |
| EV / EBITDA | 65.04 | 79.80 | 80.06 | 57.39 |
| Quality | ||||
| ROIC | 4.18% | 3.26% | 4.81% | 6.01% |
| Gross Margin | 28.91% | 29.85% | 33.45% | 36.58% |
| Cash Conversion Ratio | 1.30 | 2.64 | 0.46 | 1.83 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.38% | 4.72% | 4.77% | 4.43% |
| Free Cash Flow Growth | -46.23% | 530.90% | -87.21% | 97.67% |
| Safety | ||||
| Net Debt / EBITDA | 0.12 | -1.19 | -0.26 | -0.27 |
| Interest Coverage | 37.36 | 153.69 | 288.02 | 228.21 |
| Efficiency | ||||
| Inventory Turnover | 53.92 | 47.45 | 55.27 | 49.54 |
| Cash Conversion Cycle | 22.97 | 18.24 | 31.43 | 16.10 |